Abstract
In this study the incidence and contributing factors of iron overload in paediatric patients treated with intermittent haemodialysis were evaluated. Particular attention was given to the diagnostic value of serum ferritin in the assessment of body iron stores in patients with hepatocellular damage. The results of treatment of secondary haemosiderosis with desferrioxamine (DFO) are reported. Serum ferritin levels were measured in 18 children and adolescents undergoing long-term haemodialysis; 8 of these had biochemical evidence of hepatocellular damage. In all patients a good correlation was found between serum ferritin levels and the amount of iron stored in the reticuloendothelial system. Six patients developed iron overload. Patients with secondary haemosiderosis were younger at the start of haemodialysis and received significantly more blood. Although not significant, more patients with haemochromatosis-associated alleles and bilateral nephrectomy had iron overload, and the duration of dialysis was obviously longer for overloaded patients (40 months versus 26 months). The patients with iron overload were treated with DFO. The data from all patients showed that DFO was ineffective when administered at a dose of 25 mg/kg during dialysis and that in individual patients changes in serum ferritin correlated with changes in the amount of blood transfusions administered.
Similar content being viewed by others
References
Schafer AI, Cheron RG, Luhy R, Cooper B, Gleason RE, Soeldner JS, Bunn HF (1981) Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med 304:319–324
Müller-Wiefel DE, Waldherr R, Feist D, Kaick G van (1984) The assessment of iron stores in children on regular dialysis treatment. Contrib Nephrol 38:141–152
McGonigle RJS, Keogh AM, Weston MJ, Parsons V (1984) Iron status in chronic hemodialysis patients-treatment of transfusional iron overload with Desferrioxamine. Dial Transplant 13:214–219
Ellis D (1979) Serum ferritin compared with other indices or iron status in children and teenagers undergoing maintenance hemodialysis. Clin Chem 25:741–744
Lipschitz DA, Cook JD, Finch CA (1974) A clinical evaluation of serum ferritin as an index of iron stores. J Med 290:1213–1216
Marco-Franco JE, Alarcon A, Morey A, Piza C, Bestard J, Mairata S, Galmes A, Dolmau M (1982) Serum ferritin in hemodialysis. Nephron 32:57–59
Moreb J, Popovtzer MM, Friedlaender MM, Konijn AM, Hershko C (1981) Evaluation of iron status in patients on chronic hemodialysis: relative usefulness of bone marrow hemosiderin, serum ferritin, transferrin saturation, mean corpuscular volume and red cell protoporphyrin. Nephron 35:196–200
Van de Vijver FL, Vanheule AA, Majelyne WM, D'Haese P, Blockx PP, Bekaert AB, Buysens N, Keersmaecker W de, Broe MA de (1984) Serum ferritin as a guide for iron stores in chronic hemodialysis patients. Kidney Int 26: 451–458
Müller-Wiefel DE, Wolf E, Schönberg D, Schärer K (1978) Serum ferritin concentrations in children with chronic renal failure. Proc Eur Dial Transplant Assoc 15: 625–627
Eastham EJ, Bell JI, Douglas AP (1976) Serum ferritin levels in acute hepatocellular damage from Paracetamol overdosage. Br Med J 293:750–751
Prieto J, Barry M, Sherlock S (1975) Serum ferritin in patients with iron overload and with acute and chronic liver disease. Gastroenterology 68:525–533
Müller-Wiefel DE, Lenhard V, Schärer K (1981) Body iron stores in children with chronic renal failure in relation to HLA phenotypes. Proc Eur Dial Transplant Assoc 18:524–530
Gomez E, Ortega F, Peces R, Gago E, Martin R, Alvarez Grande J (1984) Serum ferritin in hemodialysis patients: role of blood transfusions and “haemochromatosis alleles” HLA A3, B7 and B14. Nephron 36:106–110
Baker LRI, Barnett MD, Brozovic B, Cattell WR, Ackrill P, McAlister J, Nimmon C (1976) Hemosiderosis in a patient on regular hemodialysis: Treatment by Desferrioxamina. Clin Nephrol 6:326–328
Olivieri NF, Buncic JR, Chewv E, Gallant T, Harrison RV, Keenan N, Logan W, Mitchell D, Ricci G, Skarf B, Taylor M, Freedman MH (1986) Visual and auditory neurotoxicity in patients receiving subcutaneous Desferrioxamine infusions. N Engl J Med 314:869–873
Goodill JJ, Abuelo JG (1987) Mucormycosis: a new risk of Desferrioxamine therapy in dialysis patients with aluminium or iron overload. 317:54
Miles LFM, Lipschitz DA, Bieber LP, Cook JD (1974) Measurement of serum ferritin by a 2-site immuno-radiometric assay. Anal Biochem 61:209–224
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eijgenraam, F.J., Donckerwolcke, R.A. & van Dijken, P.J. Diagnosis and treatment of iron overload in paediatric patients on chronic haemodialysis. Pediatr Nephrol 2, 303–308 (1988). https://doi.org/10.1007/BF00858682
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00858682